October 27, 2009 (FinancialWire) -- Inovio Biomedical Corp.'s (AMEX: INO | Quote | Chart | News | PowerRating) (Current Market Cap: $123.19 Mil.) board has elected David J. Williams and Keith H. Wells as directors.
Williams is the former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group. Wells is a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute.
San Diego-based Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).
http://www.financialwire.net

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index